Prescription drug markets have yet to align with the drive for value-based care in the provider market, and plenty of hurdles stand in the way of that process, experts say.
The challenge of designing new payment models for prescription drugs
Prescription drug markets have yet to align with the drive for value-based care in the provider market, and plenty of hurdles stand in the way of that process, experts say.